<DOC>
	<DOCNO>NCT01171807</DOCNO>
	<brief_summary>The purpose study investigate efficacy safety erythrocyte-mediated delivery dexamethasone steroid-dependent ulcerative colitis patient</brief_summary>
	<brief_title>Erythrocytes-Mediated Delivery Of Dexamethasone 21-Phosphate In Steroid-Dependent Ulcerative Colitis</brief_title>
	<detailed_description>Medical treatment patient ulcerative colitis ( UC ) present constant challenge . Corticosteroids effective majority patient , benefit offset adverse event . For steroid-dependent patient therapeutic choice limit azathioprine/6-mercaptopurine , methotrexate infliximab ; however , 25 % patient respond , become intolerant , contraindication ( e.g . history neoplasia ) drug . A novel method corticosteroid delivery load dexamethasone 21-phosphate red blood cell validate . Owing long life span circulation capability cellular membrane open resealed appropriate condition , erythrocytes excellent drug carrier . An ideal drug encapsulate erythrocytes Dex 21-P , biologically inactive compound undergoes dephosphorylation intra-erythrocyte enzyme release active metabolite , dexamethasone , simple passive diffusion cell membrane . In previous pilot study cohort steroid-dependent patient inactive inflammatory bowel disease , Dexamethasone 21-phosphate load autologous erythrocyte allow complete withdrawal systemic steroid , overall cumulative exposure corticosteroid Dex 21-P-encapsulated erythrocyte ( 5-10 mg per month ) far less conventional corticosteroid , translate low rate steroid-related event .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>adult patient steroiddependent ulcerative colitis clinical remission mild clinical activity uncontrolled diabetes severe comorbidities ( renal failure , heart failure , cirrhosis , neoplasia ) previous exposure biologic therapy pregnancy breast feed alcohol drug abuse mental illness</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2003</verification_date>
	<keyword>Ulcerative colitis</keyword>
	<keyword>Steroid-dependency</keyword>
	<keyword>Steroid adverse event</keyword>
	<keyword>Erythrocytes</keyword>
</DOC>